PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34111829-0	2021	A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.	hydroxamates	62-74	histone deacetylase 2	Homo sapiens	33-38	
34111829-0	2021	A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.	hydroxamates	62-74	protein tyrosine kinase 2	Homo sapiens	39-42	
34111829-0	2021	A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.	Benzamides	75-85	histone deacetylase 2	Homo sapiens	33-38	
34111829-0	2021	A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.	Benzamides	75-85	protein tyrosine kinase 2	Homo sapiens	39-42	
34111829-0	2021	A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.	pyridinyl-1,2,4-triazoles	96-121	histone deacetylase 2	Homo sapiens	33-38	
34111829-0	2021	A first-in-class anticancer dual HDAC2/FAK inhibitors bearing hydroxamates/benzamides capped by pyridinyl-1,2,4-triazoles.	pyridinyl-1,2,4-triazoles	96-121	protein tyrosine kinase 2	Homo sapiens	39-42	
34111829-1	2021	Novel 5-pyridinyl-1,2,4-triazoles were designed as dual inhibitors of histone deacetylase 2 (HDAC2) and focal adhesion kinase (FAK).	5-pyridinyl-1,2,4-triazoles	6-33	histone deacetylase 2	Homo sapiens	70-91	
34111829-1	2021	Novel 5-pyridinyl-1,2,4-triazoles were designed as dual inhibitors of histone deacetylase 2 (HDAC2) and focal adhesion kinase (FAK).	5-pyridinyl-1,2,4-triazoles	6-33	histone deacetylase 2	Homo sapiens	93-98	
34111829-1	2021	Novel 5-pyridinyl-1,2,4-triazoles were designed as dual inhibitors of histone deacetylase 2 (HDAC2) and focal adhesion kinase (FAK).	5-pyridinyl-1,2,4-triazoles	6-33	protein tyrosine kinase 2	Homo sapiens	104-125	
34111829-1	2021	Novel 5-pyridinyl-1,2,4-triazoles were designed as dual inhibitors of histone deacetylase 2 (HDAC2) and focal adhesion kinase (FAK).	5-pyridinyl-1,2,4-triazoles	6-33	protein tyrosine kinase 2	Homo sapiens	127-130